AwardedSpainGoodsFramework agreement
Adquisición estimada de 46.000 dosis de la vacuna frente a Meningococo de Serogrupo B para el Programa de Vacunaciones de la Comunidad Autónoma de Extremadura, en ejecución del Acuerdo Marco del Ministerio de Sanidad . - Expediente 202507ACM001. Lote 16.
- Published
- Published 17 June 2026
Overview
The Extremadura regional health authority has awarded a contract to GlaxoSmithKline SA for the supply of approximately 46,000 doses of Meningococcal Serogroup B vaccine for its vaccination programme, executed under the Ministry of Health's framework agreement for vaccine suppliers. The contract, valued at €2,668,000, was awarded on 11 June 2026 as part of a broader framework covering vaccine procurement for various public administration bodies across Spain.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 17 June 2026
Vaccines
Award outcome
- Awarded value
- €2,668,000
- Award date
- 11 June 2026
- GlaxoSmithKline SA
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
17 June 2026
Contracting authority
Dirección General de Planificación Económica
Procuring entityMérida, Spain
ID_PLATAFORMA: 20994040143164
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.